Abstract

Targeted DamID (TaDa) is an increasingly popular method of generating cell-type-specific DNA-binding profiles in vivo. Although sensitive and versatile, TaDa requires the generation of new transgenic fly lines for every protein that is profiled, which is both time-consuming and costly. Here, we describe the FlyORF-TaDa system for converting an existing FlyORF library of inducible open reading frames (ORFs) to TaDa lines via a genetic cross, with recombinant progeny easily identifiable by eye color. Profiling the binding of the H3K36me3-associated chromatin protein MRG15 in larval neural stem cells using both FlyORF-TaDa and conventional TaDa demonstrates that new lines generated using this system provide accurate and highly reproducible DamID-binding profiles. Our data further show that MRG15 binds to a subset of active chromatin domains in vivo. Courtesy of the large coverage of the FlyORF library, the FlyORF-TaDa system enables the easy creation of TaDa lines for 74% of all transcription factors and chromatin-modifying proteins within the Drosophila genome.

Details

Title
FlyORF-TaDa allows rapid generation of new lines for in vivo cell-type-specific profiling of protein–DNA interactions in Drosophila melanogaster
Author
Aughey, Gabriel N 1 ; Delandre, Caroline 2 ; McMullen, John P D 2 ; Southall, Tony D 1 ; Marshall, Owen J 2 

 Imperial College London, Sir Ernst Chain Building, South Kensington Campus, London SW7 2AZ, UK 
 Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart 7000, Australia 
Publication year
2021
Publication date
Jan 2021
Publisher
Oxford University Press
e-ISSN
21601836
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3169740769
Copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Genetics Society of America. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.